Academic Bibliography

Search 200 years of publications by Ghent University researchers.

dr. Elena Catanzaro

Faculty of Medicine and Health Sciences > Department of Human Structure and Repair

ORCID iD: 0000-0001-7699-3414

Add to list
- Journal Article
- A1
- open access
Ferroptosis-armed dendritic cell vaccines for glioma immunotherapy

Mariia Saviuk (UGent) , Victoria D. Turubanova, Sara De Brée (UGent) , Sandra Van Lint (UGent) , Teresa Mendes Maia, Simon Devos (UGent) , Iuliia Efimova (UGent) , Julie Braet (UGent) , Lore Van Oudenhove, Gitta Boons, et al.

(2026) NATURE COMMUNICATIONS.
Add to list
- Journal Article
- A1
- open access
Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors

Elena Catanzaro (UGent) , Manuel Beltran-Visiedo, Lorenzo Galluzzi and Dmitri Krysko (UGent)

(2025) CELLULAR & MOLECULAR IMMUNOLOGY. 22(1). p.24-39
Add to list
- Conference Paper
- C3
Enhancing anti-cancer immunity through immunogenic cell death : the role of endothelial cells in the tumor microenvironment

Faye Naessens (UGent) , Robin Demuynck (UGent) , Olga Vershinina, Iuliia Efimova, Elena Catanzaro (UGent) , Mariia Saviuk (UGent) , Louis Van der Meeren (UGent) , Maria Vedunova, Frauke Coppieters (UGent) , Mikhail Ivanchenko, et al.

(2024) JOURNAL OF IMMUNOLOGY. In Journal of Immunology 212(1, Supplement S).
Add to list
- Journal Article
- A1
- open access
CX3CL1 release during immunogenic apoptosis is associated with enhanced anti-tumour immunity

Faye Naessens (UGent) , Robin Demuynck (UGent) , Olga Vershinina, Iuliia Efimova (UGent) , Mariia Saviuk (UGent) , Greet De Smet (UGent) , Tatiana A. Mishchenko, Maria V. Vedunova, Olga Krysko (UGent) , Elena Catanzaro (UGent) , et al.

(2024) FRONTIERS IN IMMUNOLOGY. 15.
Add to list
- Journal Article
- A1
- open access
Immunogenicity of ferroptosis in cancer : a matter of context?

Elena Catanzaro (UGent) , Robin Demuynck (UGent) , Faye Naessens (UGent) , Lorenzo Galluzzi and Dmitri Krysko (UGent)

(2024) TRENDS IN CANCER. 10(5). p.407-416
Add to list
- Miscellaneous
- open access
Ferroptosis : friend or foe in cancer immunotherapy?

Robin Demuynck (UGent) , Iuliia Efimova (UGent) , Elena Catanzaro (UGent) and Dmitri Krysko (UGent)

(2023) ONCOIMMUNOLOGY. 12(1).
Add to list
- Journal Article
- A1
- open access
Perillaldehyde is a new ferroptosis inducer with a relevant clinical potential for acute myeloid leukemia therapy

Elena Catanzaro (UGent) , Eleonora Turrini, Tessa Kerre (UGent) , Simon Sioen, Ans Baeyens (UGent) , Alessandra Guerrini, Mohamed Lamin Abdi Bellau, Gianni Sacchetti, Guglielmo Paganetto, Dmitri Krysko (UGent) , et al.

(2022) BIOMEDICINE & PHARMACOTHERAPY. 154.
Add to list
- Journal Article
- A1
- open access
In vitro veritas : from 2D cultures to organ-on-a-chip models to study immunogenic cell death in the tumor microenvironment

Dmitri Krysko (UGent) , Robin Demuynck (UGent) , Iuliia Efimova (UGent) , Faye Naessens (UGent) , Olga Krysko (UGent) and Elena Catanzaro (UGent)

(2022) CELLS. 11(22).
Add to list
- Journal Article
- A1
- open access
Immunogenic cell death and role of nanomaterials serving as therapeutic vaccine for personalized cancer immunotherapy

Elena Catanzaro (UGent) , Olivier Feron, Andre Skirtach (UGent) and Dmitri Krysko (UGent)

(2022) FRONTIERS IN IMMUNOLOGY. 13.
Add to list
- Conference Paper
- C3
- open access
Cell death stage dictates the immunogenicity of ferroptotic cancer cells

Iuliia Efimova (UGent) , Elena Catanzaro (UGent) , Robin Demuynck (UGent) , Louis Van der Meeren (UGent) , Frauke Coppieters (UGent) , Claus Bachert (UGent) , Andre Skirtach (UGent) , Olga Krysko (UGent) and Dmitri Krysko (UGent)

(2021) Virtual IMMUNOLOGY2021. In Journal of Immunology 206(Suppl. 1).

1
2

Next →